Akèy › Obèsite › Texas

Etid klinik pou Obèsite nan Texas

81 etid pou Obèsite ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Baylor Scott & White Institute for Research, Dallas

Ap rekrite

Laj 18 a 70 · Tout sèks · Mizajou Sep 30, 2026 · NCT06003686

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
ak 2 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

DM Clinical, Houston
DM Clinical, San Antonio
The Texas Liver Institute, San Antonio
ak 3 plis

Ap rekriteFaz 3

Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

UT Southwestern Med Center, Dallas
PlanIt Research, PLLC, Houston

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Amarillo Medical Specialists /ID# 282380, Amarillo
Elligo Clinical Research Center /ID# 282166, Austin
Velocity Clinical Research - Dallas /ID# 282734, Dallas
ak 2 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Amarillo Medical Specialists, Amarillo
North Texas Endocrine Center, Dallas

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

PlanIt Research, LLC (Monitoring Room), Houston
PlanIt Research, LLC, Houston
VIP Trials, San Antonio

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Amarillo Med Spec LLP, Amarillo
Texas Diabetes & Endocrinology, Austin
Pinnacle Clinical Research, Brownsville
ak 7 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Endeavor Clinical Trials, San Antonio

Ap rekriteFaz 1

Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Houston

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Dell Children's Medical Center - PIN, Austin
Driscoll Children's Hospital, Corpus Christi
McGovern Medical School, Houston
ak 4 plis

Ap rekriteFaz 3

Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Amarillo Medical Specialists, Amarillo
Velocity Clinical Res-Dallas, Dallas
Care United Research, LLC, Forney

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07339423

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Research of San Antonio, San Antonio
Southern Star Research Institute, San Antonio
Tyler Research Institute, Tyler

Ap rekriteFaz 3

Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastroenterology Research of San Antonio, San Antonio
Southern Star Research Institute, San Antonio
Tyler Research Institute, Tyler

Ap rekriteFaz 3

Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Mercy Family Clinic, Dallas
Juno Research, Houston
Biopharma Informatic, LLC, Houston
ak 2 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07153471

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

IMA Clinical Research Austin, Austin
Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
Velocity Clinical Research, Dallas, Dallas
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

PharmaTex Research, LLC, Amarillo
Austin Heart, Austin
Velocity Clinical Research - Austin, Austin
ak 22 plis

Ap rekriteFaz 3

Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

JCCT - Juno Bellaire Site, Bellaire
Epic Medical Research - DeSoto, DeSoto
Valley Institute of Research - Fort Worth, Fort Worth
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

The University of Texas Health Science Center at Houston, Bellaire
Velocity Clinical Research, Dallas, Dallas
UT Southwestern Medical Center, Dallas
ak 1 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, DeSoto
Research Site, El Paso
Research Site, Houston
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

IMA Clinical Research Austin, Austin
FutureSearch Trials of Dallas, Dallas
PlanIt Research, PLLC, Houston
ak 2 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

UT Southwestern Medical Center, Dallas
Juno Research, Houston
Activian Clinical Research, Kingwood
ak 7 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

FutureSearch Trials of Neurology, Austin
Sleep Therapy Research Center, San Antonio
Consano Clinical Research, LLC, Shavano Park

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011

Semaglutide for Post-Smoking Cessation Weight Management

The University of Texas at Austin, Austin
The University of Texas Health Science Center at Houston, Houston

Ap rekriteFaz 2Volontè an sante akeyi

Laj 18 a 75 · Tout sèks · Mizajou Sep 21, 2026 · NCT06173778

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

PharmaTex Research, LLC, Amarillo
Austin Heart, Austin
Javara Research, Conroe
ak 13 plis

Ap rekriteFaz 3

Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Austin
AURORA-2 Clinical Site, Brownsville
AURORA-2 Clinical Site, DeSoto
ak 10 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Austin
AURORA-1 Clinical Site, Brownsville
AURORA-1 Clinical Site, DeSoto
ak 8 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Headlands Research Brownsville, Brownsville
Velocity Clinical Research, Dallas
South Texas Research Institute - Edinburg, Edinburg
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Bellaire Clinical Research, LLC, Bellaire
South Texas Research Institute - Brownsville, Brownsville
South Texas Clinical Research, Corpus Christi
ak 8 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Juno Research, Houston
Southern Endocrinology Associates, Mesquite
Texas Diabetes & Endocrinology, P.A., Round Rock
ak 2 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

Research Site, Webster

Ap rekriteFaz 1/2Volontè an sante akeyi

Laj 25 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07815678

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Austin
ACCOMPLISH-2 Research Site, Farmers Branch
ACCOMPLISH-2 Research Site, Houston
ak 4 plis

Ap rekriteFaz 3Volontè an sante akeyi

Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Epic Medical Research, DeSoto
Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
Biorhythms Center for Integrative Sleep Medicine, El Paso
ak 3 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Epic Medical Research, DeSoto
Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
Biorhythms Center for Integrative Sleep Medicine, El Paso
ak 3 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07571109

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Cedar Health Research, Dallas

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07770841

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Mercy Family Clinic, Dallas
Velocity Clinical Research, Dallas, Dallas
Biopharma Informatic, LLC, Houston
ak 5 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

IMA Clinical Research Austin, Austin
Velocity Clinical Research, Dallas, Dallas
FutureSearch Trials of Dallas, Dallas
ak 3 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

ICON, San Antonio

Ap rekriteFaz 1Volontè an sante akeyi

Laj 18 a 55 · Tout sèks · Mizajou Sep 4, 2026 · NCT07767175

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Bellaire Dermatology Associates, Bellaire
Modern Research Associates, PLLC, Dallas
Center for Clinical Studies, Houston
ak 3 plis

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Amarillo
Kailera Clinical Site, Brownsville
Kailera Clinical Site, DeSoto
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.